Antares Pharma, Inc. (ATRS)

[jab91252]

scubasteve: from Antares investor presentation, a big YES to your question. The only question will be how soon will they seal a deal now that the approval is in hand. I'm guessing they have been 'talking' with potential partners but now with FDA approval Antares has greater leverage in talks with others.



Priority Goals for Next 12-18 Months
• OTREXUP™ approval and launch
• VIBEX™ QS T (testosterone) to complete clinical studies
• VIBEX™ QS M to begin clinical studies
• Teva programs advance including both multi-dose pen
products filed
• TevTropin® 10 mg approval and launch
• International OTREXUP™ partnership
• OTREXUP™ partnership - Psoriasis